Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma: A comparison with intensity-modulated radiotherapy and a spot size variation assessment

Strahlentherapie und Onkologie

Volumn 188, Issue 3, 2012, Pages 216-225

  Lorentini, S ^a,b   Amichetti, M ^a   Spiazzi, L ^c   Tonoli, S ^c   Magrini, S M ^c   Fellin, F ^a   Schwarz, M ^a  

^a ATreP Agenzia Provinciale per la Protonterapia   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Department of Paediatrics   (Italy)

Author keywords

Intensity modulated proton therapy; Intensity modulated radiation therapy; Mesothelioma; NTCP analysis; Spot size

Indexed keywords

ADULT; AGED; ARTICLE; BEAM THERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; IRRADIATION; MALE; PLEURA MESOTHELIOMA; PROTON THERAPY; RADIATION DOSE; RISK ASSESSMENT; TREATMENT PLANNING;

AGED; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; ORGAN SPARING TREATMENTS; ORGANS AT RISK; PHOTONS; PLEURAL NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84862672267     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-0038-3     Document Type: Article

References (43)

1. Ahamad A, Stevens CW, Smythe WR et al (2003) Intensity- modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 55:768-775 (Pubitemid 36170016)
2. Alber M, Birkner M, Laub W et al (2000) Hyperion: an integrated IMRT planning tool. In: Schlegel W, Bortfeld T (eds) Proceedings of 13th International Conference on the Use of Computers in Radiation Therapy. Springer, Heidelberg, Germany, pp 46-48
3. Allen AM, Czerminska M, Janne PA et al (2006) Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 65:640-645 (Pubitemid 43795851)
4. Allen AM, Schofield D, Hacker F et al (2007) Restricted field IMRT dramatically enhances IMRT planning for mesothelioma. Int J Radiat Oncol Biol Phys 69:1587-1592 (Pubitemid 350116418)
5. Allen AM, Den R, Wong JS et al (2007) Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural. Int J Radiat Oncol Biol Phys 68:1366-1374 (Pubitemid 47176807)
6. Baldini EH, Recht A, Strauss GM et al (1997) Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 63:334-338 (Pubitemid 27084548)
7. Belderbos J, Heemsbergen W, Hoogeman M et al (2005) Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol 75:157-164 (Pubitemid 40805244)
8. Buduhan G, Menon S, Aye R et al (2009) Trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 88:870-876
9. Dessy F, Linthout N, Gillis S, Closset M (2011) IBA proton pencil beam scanning: validation. Radiother Oncol 99(Supp1):S529
10. Dawson LA, Normolle D, Balter JM et al (2002) Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53:810-821 (Pubitemid 34722625)
11. Dhalluin X, Scherpereel A (2010) Treatment of malignant pleural mesothelioma: current status and future directions. Monaldi Arch Chest Dis 73:79-85
12. Emami B, Lyman J, Brown A et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109-122
13. Forster KM, Smythe WR, Starkschall G et al (2003) Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. Int J Radiat Oncol Biol Phys 55:606-616 (Pubitemid 36170001)
14. Haber SE, Haber JM (2010) Malignant mesothelioma: a clinical study of 238 cases. Ind Health 49:166-172
15. Hentschel B, Oehler W, Strauss D et al (2011) Definition of the CTV prostate in CT and MRI by using CT-MRI image fusion in IMRT planning for prostate cancer. Strahlenther Onkol 187:183-190
16. Hillbrand M, Georg D (2010) Assessing a set of optimal user interface parameters for intensity-modulated proton therapy planning. J Appl Clin Med Phys 11:93-104
17. Inoue T, Oh RJ, Shiomi H (2011) New approach for treatment of vertebral metastases using intensity-modulated radiotherapy. Strahlenther Onkol 187:108-113
18. Jeleñ U, Alber M (2007) A finite size pencil beam algorithm for IMRT dose optimization: density corrections. Phys Med Biol 52:617-633 (Pubitemid 46646435)
19. Krayenbuehl J, Oertel S, Davis JB, Ciernik IF (2007) Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy. Int J Radiat Oncol Biol Phys 69:1593-1599 (Pubitemid 350116423)
20. Krayenbuehl J, Hartmann M, Lomax AJ et al (2010) Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy. Int J Radiat Oncol Biol Phys 78:628-634
21. Kristensen CA, Nøttrup TJ, Berthelsen AK et al (2009) Pulmonary toxicity following IMRT after extrapleural pneumonectomy form malignant pleural mesothelioma. Radiother Oncol 92:96-99
22. Lomax A (1999) Intensity modulation methods for proton radiotherapy. Phys Med Biol 44:185-206
23. Lucchi M, Chella A, Melfi F et al (2007) A phase II study of intrapleural immunochemotherapy, pleurectomy/ decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL- 2 in stage II-III malignant pleural mesothelioma. 31:229-234 (editorial comment 234-235)
24. Marks LB, Bentzen SM, Deasy JO et al (2010) Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 73:70-76
25. Miles EF, Larrier NA, Kelsey CR et al (2008) Intensity- modulated radiotherapy for resected mesothelioma: the Duke experience. Int J Radiat Oncol Biol Phys 71:1143-1150
26. Mirabelli D, Cavone D, Merler E et al (2010) Nonoccupational exposure to asbestos and malignant mesothelioma in the Italian National Registry of Mesotheliomas. Occup Environ Med 67:792-794
27. Münter MW, Nill S, Thilmann C et al (2003) Stereotactic intensity-modulated radiation therapy (IMRT) and inverse treatment planning for advanced pleural mesothelioma. Feasibility and initial results. Strahlenther Onkol 179:535-541 (Pubitemid 36966410)
28. Pinkawa M, Piroth MD, Holy R et al (2011) Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer. Strahlenther Onkol 187:479-484
29. Pinto C, Ardizzoni A, Betta PG et al (2011) Expert opinions of the First Italian Consensus Conference on the management of malignant pleural mesothelioma. Am J Clin Oncol 34:99-109
30. Rice DC, Craig WS, Correa AM (2007) Outcomes after extrapleural pneumonectomy and intensitymodulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 84:1685-1693 (Pubitemid 47588107)
31. Rice DC, Smythe WR, Liao Z et al (2007) Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 69:350-357 (Pubitemid 47381562)
32. Rusch VW, Rosenzweig K, Venkatraman E et al (2001) A phase II trial of surgical resection and adjuvant high-dose hemitoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 122:788-795
33. Scorsetti M, Bignardi M, Clivio A et al (2010) Volumetric modulation arc radiotherapy compared with static gantry intensity-modulated radiotherapy for malignant pleural mesothelioma tumor: a feasibility study. Int J Radiat Oncol Biol Phys 77:942-349
34. Soukup M, Fippel M, Alber M (2005) A pencil beam algorithm for intensity modulated proton therapy derived from Monte-Carlo simulations. Phys Med Biol 50:5089-5104 (Pubitemid 41503992)
35. Sterzing F, Sroka-Perez G, Schubert K et al (2008) Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-and-shoot IMRT. Radiother Oncol 86:251-257
36. Sterzing F, Schubert K, Sroka-Perez G et al (2008) Helical tomotherapy. Experiences of the first 150 patients in Heidelberg. Strahlenther Onkol 184:8-14
37. Stevens CW, Forster K, Zhu X et al (2005) Excellent local control and survival after extrapleural pneumonectomy and IMRT for mesothelioma. Int J Radit Oncol Biol Phys 63:103-104
38. Stieler F, Wolff D, Bauer L et al (2011) Reirradiation of spinal column metastases: comparison of several treatment techniques and dosimetric validation for the use of VMAT. Strahlenther Onkol 187:406-415
39. Straif K, Benbrahim-Tallaa L, Baan R et al (2009) A review of human carcinogens - part C: metals, arsenic, dusts, and fibres. Lancet Oncol 10:453-454
40. Tonoli S, Vitali P, Scotti V et al (2011) Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series. Radiother Onkol 101:311-315
41. Tsao AS, Wistuba I, Roth JA, Kindler HL (2009) Malignant pleural mesothelioma. J Clin Oncol 27:2081-2090
42. Vandenbroucke E, Praet M, Vermaelen K et al (2009) Trimodality treatment of early stage malignant pleural mesothelioma (MPM): a single institution experience. J Thorac Oncol 4:S778
43. Xu ZY, Liang SX, Zhu J et al (2006) Prediction of radiation- induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma. Int J Radiat Oncol Biol Phys 65:189-195